Andreas Halvorsen's position in Rallybio is currently worth $2.46M. That's 0.01% of their equity portfolio (76th largest holding). The investor owns 5.34% of the outstanding Rallybio stock. Andreas Halvorsen acquired their 4.19M shares in Q3 2021. So far they never sold any shares in the company. The investor's estimated purchase price is $59.1M, resulting in a loss of 96%.